Accendra Health, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Accendra Health, Inc. (ACH) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 660 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2026-02-20
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-12-31 was -651.34K shares.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-09-30 was 93.00K shares, a 675.00% increase year-over-year.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-06-30 was 380.00K shares, a 24.30% decline year-over-year.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-03-31 was 179.00K shares.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2025 was 660.00 shares, a 3.65% decline from fiscal 2024.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2024 was 685.00 shares, a 36.34% decline from fiscal 2023.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 1.08K shares, a 99.96% decline from fiscal 2022.
- Accendra Health, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 2.67M shares, a 48.08% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -651.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -558.34K shares derived: sum of 2 quarters · filed 2026-02-20 | -178.34K shares derived: sum of 3 quarters · filed 2026-02-20 | 660.00 shares 10-K · filed 2026-02-20 | |
| 2025-09-30 | 93.00K shares 10-Q · filed 2025-10-31 | 473.00K shares derived: sum of 2 quarters · filed 2025-10-31 | 652.00K shares 10-Q · filed 2025-10-31 | -18.32K shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2025-06-30 | 380.00K shares 10-Q · filed 2025-08-11 | 559.00K shares 10-Q · filed 2025-08-11 | -111.31K shares derived: sum of 3 quarters · filed 2026-02-20 | -99.31K shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2025-03-31 | 179.00K shares derived: 10-K 12 month − 3 quarters · filed 2026-02-20 | -491.31K shares derived: sum of 2 quarters · filed 2026-02-20 | -479.31K shares derived: sum of 3 quarters · filed 2026-02-20 | 22.68K shares derived: sum of 4 quarters · filed 2026-02-20 | |
| 2024-12-31 | -670.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -658.32K shares derived: sum of 2 quarters · filed 2026-02-20 | -156.31K shares derived: sum of 3 quarters · filed 2026-02-20 | 685.00 shares 10-K · filed 2026-02-20 | 1.10M shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 12.00K shares 10-Q · filed 2025-10-31 | 514.00K shares derived: sum of 2 quarters · filed 2025-10-31 | 671.00K shares 10-Q · filed 2025-10-31 | ||
| 2024-06-30 | 502.00K shares 10-Q · filed 2025-08-11 | 659.00K shares 10-Q · filed 2025-08-11 | |||
| 2023-12-31 | 1.08K shares 10-K · filed 2026-02-20 | 1.74M shares 10-K · filed 2024-02-20 | |||
| 2022-12-31 | 2.67M shares 10-K · filed 2025-02-28 | ||||
| 2021-12-31 | 1.80M shares 10-K · filed 2024-02-20 | ||||
| 2020-12-31 | 1.49M shares 10-K · filed 2023-02-28 | ||||
| 2019-12-31 | 729.00K shares 10-K · filed 2022-02-23 | ||||
| 2018-12-31 | 615.00K shares 10-K · filed 2020-03-04 | 616.00K shares 10-K · filed 2019-03-06 | |||
| 2017-12-31 | 351.00K shares 10-K · filed 2019-03-06 | ||||
| 2016-12-31 | 337.00K shares 10-K · filed 2019-03-06 | ||||
| 2015-12-31 | 195.00K shares 10-K · filed 2018-02-23 | ||||
| 2014-12-31 | 201.00K shares 10-K · filed 2017-02-17 | ||||
| 2013-12-31 | 206.00K shares 10-K · filed 2016-02-25 | ||||
| 2012-12-31 | 300.00K shares 10-K · filed 2015-02-23 | ||||
| 2011-12-31 | 369.00K shares 10-K · filed 2014-02-25 | ||||
| 2010-12-31 | 124.00K shares 10-K · filed 2013-02-22 | ||||
| 2009-12-31 | 144.00K shares 10-K · filed 2012-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HENRY SCHEIN INC (HSIC) | United States | $9.536B | 23.59 |